Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > We have FDA approval on the New Drug Application!!!
View:
Post by subaru1i on Aug 16, 2023 12:56pm

We have FDA approval on the New Drug Application!!!

I hope everyone realizes this and it is up to Medipharm Labs and their global pharmaceutical partner to release that news.   

Mr. Pidduck, the CEO of Medipharm Labs stated something very important but I don't think a lot of people were really listening and paying attention to his words.   

He stated very, very, clearly:  we are waiting on the new drug monograph

That simply means, the FDA has approved the N.D.A. and that puts Mr. Pidduck and Medipharm Labs now in a waiting mode for the FDA to simply process and issue it through their system.

Athea and I, especially Athea, were waiting patiently for someone else to realize that.   You don't WAIT for a new drug monograph if the drug did not get approved by the FDA.  

So hold on boys and girls!!!
Comment by Danno13 on Aug 16, 2023 1:54pm
Good Post SUBARULI
Comment by subaru1 on Aug 16, 2023 3:35pm
If i read between the line this means that Medipharm has at least one drug ready to hit the market or my reading is false.
Comment by subaru1 on Aug 17, 2023 3:18pm
Anyone has an answer on this.
Comment by subaru1i on Aug 17, 2023 7:16pm
Yes, 3 sources: 1) Mr. Pidduck, 2) their global pharma partner, 3) they said waiting on the drug monograph.    Let's see what happens tomorrow and you're more impatient than me. 
Comment by alleyesonme on Aug 17, 2023 8:11pm
Do you remember when he mentioned the NDA and drug monograph.  Was it Q1 call....I recall mention of this as well as the 505 I was unable to make the recent call and didn't expect no update or mention...thanks. 
Comment by subaru1i on Aug 18, 2023 9:28am
LOL!!!....alleyesonme, were you listening to Athea and I five minutes ago?   I told her the waiting on drug monograph comment by Pidduck was on the Q1 CC and the 505.   The reason my discussion this morning with Athea on the drug monograph was if we were past the 45 day public review period which is well past that.   So imho, the news, which ever form it arrives ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities